Downregulation of HLA Class I Molecules in Primary Oral Squamous Cell Carcinomas and Cell Lines

Archives of Medical Research

Volumn 40, Issue 4, 2009, Pages 256-263

  Tang, Qiusha ^a   Zhang, Jianqiong ^a   Qi, Bing ^b   Shen, Chuanlai ^a   Xie, Wei ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b Jiangsu Province Hospital   (China)

Author keywords

HLA class I genes; HLA class I molecules; Oral squamous cell carcinoma

Indexed keywords

BETA 2 MICROGLOBULIN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CANCER CELL CULTURE; CHINESE; CONTROLLED STUDY; DATA ANALYSIS; DOWN REGULATION; EPITHELIUM CELL; FLOW CYTOMETRY; GENE CONTROL; GENETIC TRANSCRIPTION; HEAVY CHAIN; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSURVEILLANCE; MOUTH CARCINOMA; PRIMARY TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR ESCAPE; WESTERN BLOTTING;

ANTIVIRAL AGENTS; BETA 2-MICROGLOBULIN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOLOGIC SURVEILLANCE; INTERFERON-GAMMA; MOUTH NEOPLASMS;

EID: 67650070302     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2009.04.004     Document Type: Article

References (31)

1. Ruiz F., and Garrido F. HLA and cancer: from research to clinical impact. Immunol Today 19 (1998) 539-543
2. Benitez R., Godelaine D., Lopez M., et al. Mutations of the β2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides. Tissue Antigen 52 (1998) 520-523
3. Blanchet O., Bourge F., Zinszner H., et al. DNA binding of regulatory factors interacting with MHC-class-I gene enhancer correlates with MHC-class-I transcriptional level in class-I-defective cell lines. Int J Cancer 6 (1991) 138-141
4. Owen B., and Pease L. TAP association influences the conformation of nascent MHC class I molecules. J Immunol 162 (1999) 4677-4680
5. York A., and Rock L. Antigen processing and presentation by the class I major histocompatibility complex. Annu Rev Immunol 14 (1996) 36-42
6. Mattijssen V., Peters M., Schalkwijk L., et al. Expression in head and neck squamous-cell carcinoma is associated with clinical outcome. Int J Cancer 55 (1993) 580-536
7. Feenstra M., Veltkamp M., Kuik J., et al. HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas. Tissue Antigens 54 (1999) 235-240
8. Old M., Khan N., Verma I., et al. A multi-center study in order to further define the molecular basis of beta-thalassemia in Thailand, Pakistan, Sri Lanka, Mauritius, Syria, and India, and to develop a simple molecular diagnostic strategy by amplification refractory mutation system-polymerase chain reaction. Hemoglobin 25 (2001) 397-345
9. Stam J., Spits H., and Ploegh L. Monoclonal antibodies raised against denatured HLA B locus heavy chains permit biochemical characterization of certain HLA C locus products. J Immunol 137 (1986) 2299-2306
10. Sernee F., Ploegh L., and Schust J. Why certain antibodies cross-react with HLA A and HLA G: epitope mapping of two common MHC class I reagents. Mol Immunol 35 (1998) 177-185
11. Ibrahim C., Allory Y., Commo B., et al. Altered pattern of major histocompatibility complex expression in renal carcinoma. Am J Pathol 162 (2003) 501-508
12. Cabrera T., Lopez A., Gaforia J., et al. Analysis of HLA expression in human tumor tissues. Cancer Immunol Immunother 52 (2003) 1-9
13. Wang P., Vanky F., and Klein E. Application of isoelectric focusing for studies of major histocompatibility complex class I antigen expression on human carcinomas. Cancer Immunol Immunother 33 (1991) 65-72
14. Palmisano L., Pistillo P., Capanni C., et al. Investigation of HLA class I downregulation in breast cancer by RT-PCR. Hum Immun 62 (2001) 133-141
15. Matsui M., Machida S., Itani T., et al. Downregulation of the proteasome subunits, transporter, and antigen presentation in hepatocellular carcinoma, and their restoration by interferon-gamma. J Gastroenterol Hepatol 17 (2002) 897-896
16. Ramal M., Feenstra M., Zwan W., et al. Criteria to define HLA haplotype loss in human solid tumors. Tissue Antigens 55 (2000) 443-452
17. Maziarz T., Burakoff J., and Faller V. The regulation of exogeneous and endogeneous class I MHC genes in a human tumor cell line, k562. Mol Immunol 27 (1990) 135-146
18. Feenstra M., Bakema J., Verdaasdonk M., et al. Detection of a putative HLA-A*31012 processed (intronless) pseudogene in a laryngeal squamous cell carcinoma. Genes Chromosomes Cancer 27 (2000) 26-38
19. Tatake J., and Zeff A. Regulated expression of the major histocompatibility complex class I genes. Proc Soc Exp Biol Med 203 (1993) 405-412
20. Elsen J., Peijnenburg A., and Eggermond C. Shared regulatory elements in the promoters of MHC class I and class II genes. Immunol Today 19 (1998) 308-310
21. Matsui M., Ikeda M., and Akatsuka T. High expression of HLA-A2 on an oral squamous cell carcinoma with down-regulated transporter for antigen presentation. Biochem Biophy Res Commun 280 (2001) 1008-1019
22. Cabrera M. The double role of the endoplasmic reticulum chaperone tapasin in peptide optimization of HLA class I molecules. Scand J Immunol 65 (2007) 487-496
23. Johnsen K., France J., Nagy N., et al. Systemic deficits in transporter for antigen presentation (TAP)-1 or proteasome subunit LMP2 have little or no effect on tumor incidence. Int J Cancer 91 (2001) 366-372
24. Murakami Y., Kanda K., Yokota K., et al. Prognostic significance of immuno-proteosome subunit expression in patients with renal-cell carcinoma: a preliminary study. Mol Urol 5 (2001) 113-121
25. Eynde J., and Morel S. Differential processing of class-restricted epitopes by the standard proteasome and the immunproteasome. Curr Opin Immunol 13 (2001) 147-156
26. Yang L., and Lin Y. Determination of HLA-A, -B and -DRB1 haplotypes based on allelic homozygosity data in selected bone marrow donors of the Taiwanese marrow donor registry. Int J Immunol 34 (2007) 385-393
27. Seliger B., Hammers S., Hohne A., et al. IFN-γ-mediated coordinated transcriptional regulation of the human TAP-1 and LMP-2 genes in human renal cell carcinoma. Clin Cancer Res 3 (1997) 573-584
28. Mazzon C., Baldani B., Cecchini P., et al. IFN-γ and R-848 dependent activation of human monocyte-derived dendritic cells by Neisseria meningitidis adhesin. A. J Immunol 179 (2007) 3904-3912
29. Pedron B., Guerin V., Jacquemard F., et al. Comparison of CD8+ T cell responses to cytomegalovirus between human fetuses and their transmitter mothers. J Infect Dis 196 (2007) 1033-1041
30. Eynde J., and Morel S. Differential processing of class-restricted epitopes by the standard proteasome and the immunoproteasome. Curr Opin Immunol 13 (2001) 147-152
31. Cardozo L., and Kohanski R.A. Altered properties of the branched chain acid-preferring activity contribute to increased cleavage after branched chain residues by the immunoproteasome. J Biol Chem 273 (1998) 16764-16776